ib-meca
Small moleculeexperimental
Clinical trial activity
12 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
11
Phase 3
4
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00280917)
Timeline
Indications
Mechanism of action
- Adenosine A3 receptorAGONIST
ADORA3 agonist
Chemistry & pharmacology
Loading structure…
SMILES
CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O- Mol. weight
- 510.29 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL119709 ↗
Also known as
- 1-deoxy-1-(6-(((iodophenyl)methyl)amino)9h-purine-9-yl)-n-methyl-(d-ribofuranuronamide)
- 3-ib-meca
- cf101
- cf101
- cf101
- cf-101
- cf-101
- cf-101
- ib-meca
- ib-meca
- ib-meca
- n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
- n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide
- n(6)-ibamu
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03168256 | Phase 3 | Feb 1, 2018 | Can-Fite BioPharma, Tel Aviv University |
| NCT01905124 | Phase 2 | Jan 1, 2017 | Can-Fite BioPharma |
| NCT00837291 | Phase 2 | Nov 1, 2016 | Can-Fite BioPharma |
| NCT02647762 | Phase 3 | Sep 1, 2016 | Can-Fite BioPharma |
| NCT01265667 | Phase 2/Phase 3 (Phase 3) | Jul 1, 2011 | Can-Fite BioPharma |
| NCT01235234 | Phase 3 | Jul 1, 2011 | Can-Fite BioPharma |
| NCT01034306 | Phase 2 | Oct 1, 2010 | BioStrategics Consulting Ltd, Can-Fite BioPharma |
| NCT01033422 | Phase 2 | Oct 1, 2010 | Can-Fite BioPharma |
| NCT00556894 | Phase 2 | Feb 1, 2008 | BioStrategics Consulting Ltd, Can-Fite BioPharma |
| NCT00428974 | Phase 2 | Jun 1, 2007 | Can-Fite BioPharma, Tel Aviv University |
| NCT00349466 | Phase 2 | Jan 1, 2007 | Can-Fite BioPharma, Tel Aviv University |
| NCT00280917 | Phase 2 | Jun 1, 2006 | BioStrategics Consulting Ltd, Can-Fite BioPharma |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Can-Fite BioPharma | For profit | 12 | 12 | 2 | 2006 |
| BioStrategics Consulting Ltd | For profit | 3 | 0 | 1 | 2006 |
| Tel Aviv University | Academic/Hospital | 3 | 0 | 2 | 2007 |
3 organizations
Page 1 / 1